NCT03860272 2026-03-30Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerAgenus Inc.Phase 1 Active not recruiting499 enrolled
NCT03894215 2026-03-27RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical CancerAgenus Inc.Phase 2 Terminated211 enrolled
NCT03104699 2025-07-30A Study of AGEN2034 in Advanced Tumors and Cervical CancerAgenus Inc.Phase 1/2 Completed211 enrolled 29 charts